rood blauwe elepsis logo Belegger.nl

Sopheon Terug naar discussie overzicht

Sopheon februari 2023

6 Posts
| Omlaag ↓
  1. Tritace 6 februari 2023 08:23
    Sopheon adds former Ideagen plc executive Barnaby Kent to Board as Independent Non-Executive Director
    Notice of Results

    M&A and growth expertise will benefit Sopheon’s strategic goals

    Sopheon, the global leader in Innovation Management software and expertise, is delighted to announce the addition of Barnaby (Barney) Kent as an Independent Non-Executive Director of Sopheon’s Board of Directors. Barney becomes the seventh Sopheon Board member and the fourth Non-Executive Director. Dedicated to ensuring financial strength alongside growth objectives, Sopheon’s board encompasses a range of experiences and provides the independent judgment necessary to maintain high standards of corporate governance.

    Prior to its recent $1.3 billion acquisition by a London-based private equity firm in 2022, Barney spent nearly a decade at publicly held Ideagen plc (formerly LSE: IDEA) a software company supplying regulatory, compliance and collaboration solutions to over 10,000 organizations around the world. In his role as COO, he led Ideagen to unprecedented growth and financial delivery. Barney has more than 20 years’ experience within the technology sector and was previously CEO of Plumtree Group prior to joining Ideagen. He has a BSc (Hons) from the University of Southampton and an MBA from Edinburgh Business School.

    Barney Kent’s addition to the Board further positions Sopheon to execute its mission to empower organizations to change the world,” said Greg Coticchia, Chief Executive Officer of Sopheon. “His expertise in expanding organizations via both organic growth and M&A activities is aligned with Sopheon’s business growth goals, specifically as we continue to increase revenue in the SaaS market and look for strategic acquisition opportunities. Barney’s experience and insight will be a valuable addition to the Board as it guides Sopheon toward continued growth.
    Joining the Sopheon Board represents an exciting opportunity to assist an already thriving organization to maximize its value,” said Barney Kent. “The company’s historically strong performance, coupled with its ability to maintain positive bottom-line results while transitioning to an expanding SaaS based model, shows a deep commitment to customers and investors alike. I look forward to using my experience and skills to further Sopheon’s position as a market leader in the Innovation Management market.
    Notice of Results

    A comprehensive update and review of the year will be provided with the Company's annual results for the year ended 31 December 2022, which are expected to be announced on 23 March 2023.

    www.sopheon.com/investors/rns-release...
  2. VeniVidiMerui 6 februari 2023 22:57
    Ideagen kwam van een omzet van £43m in 2020; en is 2 jaar later overgenomen voor £1.05 miljard

    Sopheon mikt volgend jaar op een omzet van $43m

    2 jaar daarna een overname a $1.05 miljard zouden we wel voor tekenen toch ;-)
  3. VeniVidiMerui 21 februari 2023 09:27
    Gisteren 2 orders a elk precies £1m. Dus 2 x 158831 aandelen tegen koers van £6.35.

    Weet iemand daar meer over? Lijken me geen doorsnee transacties.
  4. [verwijderd] 27 februari 2023 14:34
    valt me op dat de koers steeds met weing aandelen, naar beneden wordt geharkt, dat gebeurde ook enkele jaren geleden. en toen ineens binnen de korste keren, stond ie op ruim 14 pond.
6 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.001
AB InBev 2 5.483
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.206
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.528
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.651
Aedifica 3 901
Aegon 3.258 322.670
AFC Ajax 538 7.086
Affimed NV 2 6.288
ageas 5.844 109.885
Agfa-Gevaert 14 2.048
Ahold 3.538 74.294
Air France - KLM 1.025 35.000
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.334
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.813
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.835 242.759
AMG 971 133.102
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 485
Antonov 22.632 153.605
Aperam 92 14.936
Apollo Alternative Assets 1 17
Apple 5 380
Arcadis 252 8.731
Arcelor Mittal 2.033 320.583
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.716
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.082
ASML 1.766 106.069
ASR Nederland 21 4.451
ATAI Life Sciences 1 7
Atenor Group 1 470
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.610
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.390